Is radical resection of hilar cholangiocarcinoma plus partial resection of pancreatic head justified for advanced hilar cholangiocarcinoma?

Background To outline our experience with the radical resection of hilar cholangiocarcinoma (HCCA) combined with the partial resection of the pancreatic head (RRHCCAPRPH) as a treatment for HCCA with distal bile duct involvement and to appraise the feasibility of this challenging procedure. Methods...

Full description

Saved in:
Bibliographic Details
Published in:ANZ journal of surgery 2020-09, Vol.90 (9), p.1666-1670
Main Authors: Liu, Fei, Hu, Hai‐Jie, Ma, Wen‐Jie, Wang, Jun‐Ke, Ran, Cong‐Dun, Regmi, Parbatraj, Li, Fu‐Yu
Format: Article
Language:English
Subjects:
Bile
Bile Duct Neoplasms - surgery
Bile ducts
Bile Ducts, Intrahepatic
Cholangiocarcinoma
Cholangiocarcinoma - surgery
Complications
Gastric emptying
Hepatectomy
Hepatopancreaticoduodenectomy
Hilar cholangiocarcinoma
Humans
Klatskin Tumor - surgery
Pancreas
Pancreatic
Patients
Radical resection
Retrospective Studies
Surgery
Survival
Treatment Outcome
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background To outline our experience with the radical resection of hilar cholangiocarcinoma (HCCA) combined with the partial resection of the pancreatic head (RRHCCAPRPH) as a treatment for HCCA with distal bile duct involvement and to appraise the feasibility of this challenging procedure. Methods Between 2007 and 2017, 205 patients with HCCA who underwent curative surgery at our hospital were included. Among the patients, extrahepatic bile duct resection combined with hepatectomy (EBDRH), RRHCCAPRPH and hepatopancreaticoduodenectomy (HPD) was performed in 168, 21 and 16 patients, respectively. Clinical pathological factors, post‐operative complications and survival were compared between the three groups. Results There was a significant difference in operative blood loss, operative time, post‐operative hospital stay and tumour size between EBDRH group, RRHCCAPRPH group and HPD group (P 
ISSN:1445-1433
1445-2197
DOI:10.1111/ans.15955